Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


IQuity Awarded Grant to Identify Alzheimer's Earlier


 
Chase Spurlock, PhD

Nashville-based data analytics company IQuity recently received a $320,000 grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The company - which utilizes data to predict, detect and monitor chronic disease - will build upon its diagnostic expertise to try to identify Alzheimer's at an earlier point in the disease's progression.

To date, IQuity has focused its research exclusively on autoimmune and related diseases, including multiple sclerosis, fibromyalgia syndrome and inflammatory bowel disease. The new grant will allow the company to expand its focus to include Alzheimer's disease and apply its genomic expertise to develop new diagnostic tools to help providers identify the disease early.

As part of its research activity for the award, IQuity will use its new machine learning-based data mining and analytics platform - which analyzes many types of information, including genomic datasets, claims data and electronic medical records - to predict and detect Alzheimer's. IQuity launched its analytics platform in July.

"This grant is a significant validation of the promise our genomics research and data analytics capabilities holds for people suffering from this debilitating disease," said IQuity CEO Chase Spurlock, PhD. "IQuity's advances in RNA testing and data science have great potential to create predictive diagnostic tools that will lead to an earlier diagnosis of Alzheimer's. New therapies that emerge for Alzheimer's will be most effective when administered early, which is difficult with today's diagnostic approach."

Alzheimer's is the sixth leading cause of death in the U.S., with 5.7 million people suffering from the disease. The Alzheimer's Association estimates the cost of healthcare and long-term care for individuals with Alzheimer's and dementias will total $277 billion in 2018.

"All of us at IQuity are excited and honored that the NIA and NIH support our approach to developing innovative technology that can facilitate early detection and treatment responses for people affected by Alzheimer's," said Spurlock. "We are proud to be part of a global community of researchers and data scientists who are committed to discovering new early detection methods, prevention plans, treatments and, hopefully, a cure for Alzheimer's."

Web:

IQuity

 
Share:

Related Articles:


Recent Articles

Alexander Visits Neighborhood Health at East Side in Nashville

VIDEO of United States Senator Lamar Alexander (R-Tenn.) visiting the Neighborhood Health at East Side health center in Nashville, where he learned more about what the center is doing to provide access to health care services in urban, underserved areas of Nashville.

Read More

AMA Grants MycoDART CPT Code For Its Life-Saving Test

MycoDART, Inc., developer of proprietary DNA tests, announced its second patented assay has been granted a CPT code from the American Medical Association.

Read More

Low-level Alcohol Use Increases Miscarriage Risk

Women who consume alcohol during pregnancy -- even in small amounts -- have a 19% greater risk of miscarriage than women who don't use alcohol, according to a new study by Vanderbilt researchers.

Read More

Beating the Odds

Vanderbilt Children's Hospital researchers play key role in groundbreaking study.

Read More

Hot Topics in Healthcare Law

Never a dull moment ... the highly regulated nature of the healthcare industry keeps America's health lawyers hopping.

Read More

Vanderbilt Children's New Program Leaders, Rankings

Monroe Carell Jr. Children's Hospital at Vanderbilt has recently welcomed new leaders to oversee specialty programming and again been recognized nationally in multiple specialties.

Read More

Insuring Kids

Local experts offer insight over ongoing coverage concerns for Tennessee children

Read More

Services for Mom & Baby Expanding at TriStar Centennial

Innovative initiatives at TriStar Centennial designed to keep mom and baby safe, together.

Read More

Another Option to Address Pediatric ADHD

NeuroSigma recently received FDA clearance for the first device to treat pediatric ADHD, offering providers, patients and parents a new alternative to medication.

Read More

Back to School Reminders for Patients & Providers

Back-to-school season is here, and it's a great time to talk to patients and parents about starting off the year with healthy habits

Read More

Email Print
 
 

 

 


Tags:
Alzheimer’s Disease, Chase Spurlock, IQuity, Predictive Diagnostics, RNA Testing, Senior Health
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: